US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

PAVM

PAVmed (PAVM)

PAVmed Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PAVM

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/20	21 : 56	PR Newswire (US)	Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test	NASDAQ:PAVM	PAVmed Inc
2024/11/18	22 : 15	PR Newswire (US)	Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum	NASDAQ:PAVM	PAVmed Inc
2024/11/14	22 : 01	PR Newswire (US)	PAVmed Provides Business Update and Third Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
2024/11/07	22 : 01	PR Newswire (US)	Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication	NASDAQ:PAVM	PAVmed Inc
2024/11/05	22 : 01	PR Newswire (US)	Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers	NASDAQ:PAVM	PAVmed Inc
2024/10/31	21 : 31	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024	NASDAQ:PAVM	PAVmed Inc
2024/10/30	21 : 31	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024	NASDAQ:PAVM	PAVmed Inc
2024/10/15	20 : 51	PR Newswire (US)	Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test	NASDAQ:PAVM	PAVmed Inc
2024/10/10	20 : 51	PR Newswire (US)	PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care	NASDAQ:PAVM	PAVmed Inc
2024/10/09	21 : 01	PR Newswire (US)	Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit	NASDAQ:PAVM	PAVmed Inc
2024/10/08	20 : 49	PR Newswire (US)	Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024	NASDAQ:PAVM	PAVmed Inc
2024/10/01	21 : 01	PR Newswire (US)	Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players	NASDAQ:PAVM	PAVmed Inc
2024/09/24	21 : 01	PR Newswire (US)	American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test	NASDAQ:PAVM	PAVmed Inc
2024/09/17	05 : 30	PR Newswire (US)	PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements	NASDAQ:PAVM	PAVmed Inc
2024/09/10	20 : 56	PR Newswire (US)	Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress	NASDAQ:PAVM	PAVmed Inc
2024/09/03	20 : 51	PR Newswire (US)	Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health	NASDAQ:PAVM	PAVmed Inc
2024/08/20	21 : 16	PR Newswire (US)	Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer	NASDAQ:PAVM	PAVmed Inc
2024/08/13	21 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PAVM	PAVmed Inc
2024/08/13	21 : 16	PR Newswire (US)	The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer	NASDAQ:PAVM	PAVmed Inc
2024/08/13	21 : 01	PR Newswire (US)	PAVmed Provides Business Update and Second Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
2024/08/13	05 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PAVM	PAVmed Inc
2024/08/12	21 : 07	PR Newswire (US)	Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
2024/08/08	21 : 31	PR Newswire (US)	Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event	NASDAQ:PAVM	PAVmed Inc
2024/08/06	21 : 15	PR Newswire (US)	Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing	NASDAQ:PAVM	PAVmed Inc
2024/08/05	21 : 15	PR Newswire (US)	Lucid Diagnostics to Participate in Upcoming Investor Conferences	NASDAQ:PAVM	PAVmed Inc
2024/07/30	21 : 15	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024	NASDAQ:PAVM	PAVmed Inc
2024/07/29	21 : 15	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024	NASDAQ:PAVM	PAVmed Inc
2024/07/23	21 : 01	PR Newswire (US)	Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume	NASDAQ:PAVM	PAVmed Inc
2024/07/11	21 : 31	PR Newswire (US)	Lucid Diagnostics Launches New Corporate Website	NASDAQ:PAVM	PAVmed Inc
2024/07/02	20 : 55	PR Newswire (US)	Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population	NASDAQ:PAVM	PAVmed Inc

Showing the most relevant articles for your search:NASDAQ:PAVM

1 2 3 4 5 6 7 8 9 10 次へ >>

Deutsche Telekom (QX)

Bank of America

American Express

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約